French focus on stem cell market
03.05.2012 - Cellectis has enlisted Mathieu Simon as a new Senior Vice-president. Simon brings in more than 25 years of leadership experience at Wyeth and Groupe Pierre Fabre.
Simon will coordinate the activities of company subsidiaries Cellectis Therapeutics, Ectycell and Cellartis, which represent the young stem cell business of the French specialist for genome engineering. The new VP has extensive experience in marketing and sales of pharmaceuticals in Europe. Since 2011, Simon has been acting as an advisor to both financial institutions and other companies in the sector.